19 June 2013
According to a new US review, elevated blood concentrations and intakes of magnesium may decrease the risk of developing cardiovascular disease by 30 %.
The review and meta-analysis comprised 16 prospective studies providing the blood magnesium levels and estimated intakes as well as documented cases of cardiovascular disease (CVD), including ischemic heart disease (IHD), among a total of 313,041 participants (1). The analysis showed that the risk of developing cardiovascular disease was reduced by 30 % in participants with incremented amounts of circulating magnesium (per 0.2 mmol/L). In addition, trends for a risk reduction of IHD and fatal IHD were shown. Higher magnesium intake (per 200 mg/day) was not significantly associated with CVD but was associated with a 22 % lower risk of IHD.
The researchers noted that these findings supported the need for clinical trials to evaluate the potential role of magnesium in the prevention of CVD. Observational and experimental studies have shown that magne-sium can exert beneficial effects on the cardiovascular system by enhancing endothelium-dependent vasodilation, improving lipid metabolism, reducing inflammation and inhibiting platelet function (2). Although marked reductions in magnesium concentrations or intakes produce adverse cardiovascular effects, such as heart rhythm changes (3), it remains unclear whether the CVD risk differs across the normal physiologic concentration range of circulating magnesium or dietary magnesium intake.
8 September 2015
According to a new study from the Netherlands, increased intakes of folic acid and vitamin B12 do not prevent cognitive decline in elderly people. Experts criticized that the participants already had a sufficient folic acid status at the beginning of the study.
6 May 2013
The UK National Osteoporosis Society has developed new clinical guidelines for the management of vitamin D deficiency due to a lack of national recommendations on the indications for vitamin D measurements and conflicting guidelines from various organizations.
1 December 2015
In 2000, the USA Institute of Medicine (IoM) noted that the amount of vitamin E necessary to maintain the correct metabolism of polyunsaturated fatty acids (PUFAs) in cell membranes is related to the intake of PUFAs. A recent review by Raederstorff et al. examines in detail the relationship between PUFA intake and vitamin E requirement. The basal metabolic requirement of 3 to 4 mg/day α-tocopherol needs to be increased to 12.5 to 20 mg/day, just to balance out typical intakes of PUFAs in the Western diet.
